Wednesday, November 11, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleSeeking Alpha· October 22, 2026

Lam projects more than $200B 2027 WFE as Aether revenue target rises to $2.5B by decade end

View original at seekingalpha.com
“"The September quarter was also a record for our free cash flow, coming in at $3.24 billion," (Executive VP & CFO Douglas Bettinger)”
Verbatim excerpt from the source · Seeking Alpha · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • December quarter guidance of $8.6B ±$400M revenue and EPS $2.33 ±$0.15.

    60% confidence
  • Lam delivered record revenue and profitability in the September quarter, with operating margin topping 40% for the first time.

    60% confidence
  • Etch and deposition intensity rises as device architectures move to 3D, faster if DRAM leaps from 6F2 to 3D.

    60% confidence
  • Clean room space and component supply constraints will continue to limit chip makers' and equipment companies' ability to meet end demand in 2027.

    60% confidence
  • The revenue guide would have been higher absent near-term supply chain constraints.

    60% confidence
  • Asked whether supply constraints imply a $300-400M headwind.

    60% confidence
  • Preliminary 2027 WFE outlook is more than $200B, with growth led by DRAM, then leading-edge foundry/logic and NAND.

    60% confidence
  • Declined to quantify unconstrained 2027 WFE demand but said it would be higher.

    60% confidence
  • Each percentage point of NAND bits shifting to SLC class devices requires about 2% more installed wafer capacity.

    60% confidence
  • Cumulative Aether-related revenue is expected to reach about $2.5B by end of decade, ~$1B above prior expectations.

    60% confidence
  • Services revenue to grow more than 30% in calendar 2026 and CSBG over 15% in calendar 2027.

    60% confidence
  • Shipments delayed by timing from December will ship in the March quarter.

    60% confidence
  • Current supply constraints are nothing like COVID-era shortages.

    60% confidence
  • Outgrowth versus WFE is driven by rising deposition and etch intensity across devices, advanced packaging and NAND tiering.

    60% confidence
  • China will be a significantly lower share of revenue in the December quarter, driven by domestic Chinese customers.

    60% confidence
  • 2026 WFE expected in the mid-$150 billion range, up from low-$150B last quarter.

    60% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Biotech Catalyst Wave: Late-2026 Clinical Readouts, PDUFA Dates and Capital Restructuring
A dense cluster of Q4 2026 to Q1 2027 clinical and regulatory catalysts spans hepatitis delta (Vir's ECLIPSE/SOLSTICE), hypertension and sleep apnea (Mineralys' lorundrostat, PDUFA 2026-12-22), severe hypertriglyceridemia (plozasiran), oncology (ivonescimab BLA, PDUFA 2026-11-14) and gene therapy (Krystal). Positive data flow from AASLD and AHA presentations is offset by cost-cutting guidance, milestones slipping into 2027, and a delisting process that signals capital-market stress for some issuers. Near-term value hinges on binary FDA decisions and Phase 3 topline readouts in Q1 2027.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,564 source documents archived
Query this data → isubstrate.com